Department of Chemistry, Oregon State University, Corvallis, Oregon, USA.
Org Biomol Chem. 2012 Oct 21;10(39):7884-99. doi: 10.1039/c2ob25766a.
The potent antitumor agent phorboxazole A was synthesized from six subunits comprising C1-C2 (115), C3-C8 (98), C9-C19 (74), C20-C32 (52), C33-C41 (84) and C42-C46 (85). Tetrahydropyrans B and C containing cis-2,6-disubstitution were fabricated via palladium(II)-mediated intramolecular alkoxycarbonylation which, in the case of tetrahydropyran C, was carried out with catalytic palladium(II) and p-benzoquinone as the stoichiometric re-oxidant. Tetrahydropyran D was obtained by a stereoselective tin(IV)-catalyzed coupling of a C9 aldehyde with an allylsilane, and the C19-C20 connection was made using a completely stereoselective Wittig-Schlosser (E) olefination. Coupling of the oxazole C32 methyl substituent with the intact C33-C46 δ-lactone 3was accompanied by elimination of the vinyl bromide to a terminal alkyne, but the C32-C33 linkage was implemented successfully with 83 and C33-C41 lactone 84. The C42-C46 segment of the side chain was then appended via Julia-Kocienski olefination. The macrolide portion of phorboxazole A was completed by means of an Ando-Still-Gennari intramolecular (Z)-selective olefination at C2-C3 which required placement of a (dimethoxyphosphinyl)acetate moiety at C24. Final deprotection led to phorboxazole A via a route in which the longest linear sequence is 37 steps and the overall yield is 0.36%.
从包含 C1-C2(115)、C3-C8(98)、C9-C19(74)、C20-C32(52)、C33-C41(84)和 C42-C46(85)的六个亚基合成了强效抗肿瘤剂 phorboxazole A。通过钯 (II) 介导的分子内烷氧基羰基化反应合成了含有顺式-2,6-二取代的四氢吡喃 B 和 C,在四氢吡喃 C 的情况下,使用催化钯 (II) 和对苯醌作为化学计量的氧化剂进行反应。通过立体选择性锡 (IV) 催化 C9 醛与烯丙基硅烷的偶联反应得到四氢吡喃 D,并且通过完全立体选择性的 Wittig-Schlosser(E)烯烃化反应构建了 C19-C20 连接。用完整的 C33-C46 δ-内酯 3 将 oxazole C32 甲基取代基与 oxazole C32 甲基取代基偶联时,伴随着末端炔烃的消除,但是 C32-C33 键成功地与 83 和 C33-C41 内酯 84 实现。侧链的 C42-C46 片段随后通过 Julia-Kocienski 烯烃化反应添加。Phorboxazole A 的大环部分通过在 C2-C3 处进行 Ando-Still-Gennari 分子内(Z)选择性烯烃化反应完成,这需要在 C24 处放置(二甲氧基膦酰基)乙酸酯部分。最后通过一条最长线性序列为 37 步,总收率为 0.36%的路线实现了对 phorboxazole A 的脱保护。